Low-dose Fostemsavir Extended Release Relative Bioavailability Study
Status:
Completed
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
This is a two-part study. Part 1 will evaluate relative bioavailability of temsavir (TMR)
following single dose administration of the reference fostemsavir (FTR) compared to two
low-dose ER tablet formulations of FTR. In Part 2, the effect of food on the bioavailability
of TMR will be assessed on the selected low-dose ER tablet formulation from Part 1.